Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)

NCT02598128 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency

Interventions

DEVICE: RELiZORB
DEVICE: Placebo

Sponsor

Alcresta Therapeutics, Inc.